BOne marrow parasite burden among patients with new world kala-azar is associated with disease severity

American Journal of Tropical Medicine and Hygiene

Volumn 90, Issue 4, 2014, Pages 621-626

  Silva, Joyce M ^a   Zacarias, Danielle A ^b   De Figueirêdo, Lívio C ^c   Soares, Maria Regiane A ^d   Ishikawa, Edna A Y ^e   Costa, Dorcas L ^e   Costa, Carlos H N ^e  

^a Bichos e Mimos Laboratório de Leishmanioses Instituto de Doenças Tropicais Natan Portella   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^d FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^e Instituto de Doencas Tropicais Natan Portella   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CELL NUCLEUS; CHILD; DISEASE SEVERITY; EDEMA; EPISTAXIS; FEMALE; HOSPITAL PATIENT; HUMAN; JAUNDICE; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; PARASITE LOAD; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SURVIVOR; WEIGHT REDUCTION;

ADOLESCENT; ADULT; BONE MARROW; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA, KINETOPLAST; FEMALE; HUMANS; INFANT; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; PARASITE LOAD; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84898743095     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.13-0376     Document Type: Article

References (48)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team, 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 7: e35671.
2. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL, 1996. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 124: 664-672. (Pubitemid 26103841)
3. Sampaio MJ, Cavalcanti NV, Alves JG, Filho MJ, Correia JB, 2010. Risk factors for death in children with visceral leishmaniasis. PLoS Negl Trop Dis 4: e877.
4. Seaman J, Mercer AJ, Sondorp E, 1996. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871.
5. Werneck GL, Batista MS, Gomes JR, Costa DL, Costa CH, 2003. Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil. Infection 31: 174-177. (Pubitemid 36737040)
6. Collin SD, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C, 2004. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619. (Pubitemid 38333855)
7. Kager PA, Rees PH, 1986. Hematological investigations in visceral leishmaniasis. Trop Geogr Med 38: 371-379.
8. Mishra P, Dixit A, Chatterjee T, Bhattacharya M, Bhattacharya J, Dutta P, Mahapatra M, Pati HP, Choudhry VP, Saxena R, 2004. Disseminated intravascular coagulation as an unusual presentation of kala-azar: report of two cases. Scand J Infect Dis 36: 519-521. (Pubitemid 39089218)
9. Lomtadze ML, Khochava MA, Shalamberidze IA, Kharaishvili VI, Vorob'eva EO, 2005. Study of intravascular coagulation activation markers in patients with visceral leishmaniasis. Georgian Med News 140: 47-50.
10. Andrade TM, Carvalho EM, Rocha H, 1990. Bacterial infections in patients with visceral leishmaniasis. J Infect Dis 162: 1354-1359.
11. Barral-Netto M, Diez R, Badaro R, Sampaio D, Barral A, Carvalho EM, Falcoff E, 1989. Serum interferon activity of patients with leishmaniasis. Braz J Med Biol Res 22: 1485-1487.
12. Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD Jr, 1989. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 83: 860-864. (Pubitemid 19080617)
13. Dutra M, Martinelli R, de Carvalho EM, Rodrigues LE, Brito E, Rocha H, 1985. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 6: 22-27. (Pubitemid 15020967)
14. Duarte MI, Silva MR, Goto H, Nicodemo EL, Amato Neto V, 1983. Interstitial nephritis in human kala-azar. Trans R Soc Trop Med Hyg 77: 531-537.
15. Duarte MI, Corbett CE, 1987. Histopathological patterns of the liver involvement in visceral leishmaniasis. Rev Inst Med Trop Sao Paulo 29: 131-136.
16. Duarte MI, da Matta VL, Corbett CE, Laurenti MD, Chebabo R, Goto H, 1989. Interstitial pneumonitis in human visceral leishmaniasis. Trans R Soc Trop Med Hyg 83: 73-76. (Pubitemid 19265527)
17. Ho EA, Soong TH, Li Y, 1948. Comparative merits of sternum, spleen and liver punctures in the study of human visceral leishmaniasis. Trans R Soc Trop Med Hyg 41: 629-636.
18. Veress B, Omer A, Satir AA, El Hassan AM, 1977. Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology 33: 605-610. (Pubitemid 8199185)
19. Ponce C, Ponce E, Morrison A, Cruz A, Kreutzer R, McMahon-Pratt D, Neva F, 1991. Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras. Lancet 337: 67-70.
20. Rohrs LC, 1964. Leishmaniasis in the Sudan Republic. Xviii. Parasitemia in kala-azar. Am J Trop Med Hyg 13: 265-271.
21. Kumar PV, Vasei M, Sadeghipour A, Sadeghi E, Soleimanpour H, Mousavi A, Tabatabaei AH, Rizvi MM, 2007. Visceral leishmaniasis: bone marrow biopsy findings. J Pediatr Hematol Oncol 29: 77-80. (Pubitemid 46213852)
22. Molina R, Canavate C, Cercenado E, Laguna F, Lopez-Velez R, Alvar J, 1994. Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. Aids 8: 277-279. (Pubitemid 24094133)
23. Bourgeois N, Lachaud L, Reynes J, Rouanet I, Mahamat A, Bastien P, 2008. Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. J Acquire Immune Defic Syndr 48: 13-19. (Pubitemid 351600853)
24. Ho JL, He SH, Rios MJ, Wick EA, 1992. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 or antileishmanial activity and oxidative burst capacity. J Infect Dis 165: 344-351.
25. Karp CL, el-Safi SH, Wynn TA, Satti MM, Kordofani AM, Hashim FA, Hag-Ali M, Neva FA, Nutman TB, Sacks DL, 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest 91: 1644-1648. (Pubitemid 23127368)
26. Carvalho EM, Bacellar O, Brownell C, Regis T, Coffman RL, Reed SG, 1994. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949-5956.
27. Caldas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, Brodskyn C, Costa J, Barral-Netto M, Barral A, 2005. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5: 113.
28. Peruhype-Magalhaes V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, Teixeira-Carvalho A, Figueiredo RM, Guimarães-Carvalho SF, Ferrari TC, Van Weyenbergh J, Correa-Oliveira R, 2005. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol 62: 487-495. (Pubitemid 41719325)
29. Costa DL, Rocha RL, Carvalho RM, Lima-Neto AS, Harhay MO, Costa CH, Barral-Neto M, Barral AP, 2013. Serum cytokines associated with severity and complications of kala-azar. Pathog Glob Health 107: 78-87.
30. Bain BJ, 2001. Bone marrow aspiration. J Clin Pathol 54: 657-663. (Pubitemid 32835409)
31. Shaw JJ, Ishikawa EA, Lainson R, 1989. A rapid and sensitive method for the identification of Leishmania with monoclonal antibodies using fluorescein-labeled avidin. Tran R Soc Trop Med Hyg 83: 783-784. (Pubitemid 20004488)
32. Jaffe CL, McMahon-Pratt D, 1987. Serodiagnostic assay for visceral leishmaniasis employing monoclonal antibodies. Trans R Soc Trop Med Hyg 81: 587-594.
33. Pratt DM, David JR, 1981. Monoclonal antibodies that distinguish between New World species of Leishmania. Nature 291: 581-583. (Pubitemid 11043680)
34. Rolao N, Cortes S, Rodrigues OR, Campino L, 2004. Quantification of Leishmania infantum parasites in tissue biopsies by realtime polymerase chain reaction and polymerase chain reaction-enzyme-linked immunosorbent assay. J Parasitol 90: 1150-1154. (Pubitemid 40247397)
35. Mary C, Faraut F, Lascombe L, Dumon H, 2004. Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity. J Clin Microbiol 42: 5249-5255. (Pubitemid 39506237)
36. Grover Z, Ee LC, 2009. Protein energy malnutrition. Pediatr Clin North Am 56: 1055-1068.
37. Delgado J, Pineda JA, Macias J, Regordan C, Gallardo JA, Leal M, Sanchez-Quijano A, Lissen E, 1998. Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol 36: 315-316. (Pubitemid 28047490)
38. Costa CH, Werneck GL, Costa DL, Holanda TA, Aguiar GB, Carvalho AS, Cavalcanti JC, Santos LS, 2010. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop 43: 386-392.
39. Santos-Oliveira JR, Regis EG, Leal CR, Cunha RV, Bozza PT, Da-Cruz AM, 2011. Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis 5: e1198.
40. Smith DF, Peacock CS, Cruz AK, 2007. Comparative genomics: from genotype to disease phenotype in the leishmaniases. Int J Parasitol 37: 1173-1186. (Pubitemid 47088471)
41. Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ, Reiner NE, 2012. Secreted virulence factors and immune evasion in visceral leishmaniasis. J Leukoc Biol 91: 887-899.
42. Frade AF, Oliveira LC, Costa DL, Costa CH, Aquino D, Van Weyenbergh J, Barral-Netto M, Barral A, Kalil J, Goldberg AC, 2011. TGFB1 and IL8 gene polymorphisms and susceptibility to visceral leishmaniasis. Infection, genetics and evolution. Infect Genet Evol 11: 912-916.
43. Alonso DP, Ferreira AF, Ribolla PE, de Miranda Santos IK, do Socorro Pires e Cruz M, Aecio de Carvalho F, Abatepaulo AR, Lamounier Costa D, Werneck GL, Farias TJ, Soares MJ, Costa CH, 2007. Genotypes of the mannan-binding lectin gene and susceptibility to visceral leishmaniasis and clinical complications. J Infect Dis 195: 1212-1217. (Pubitemid 46543455)
44. Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, Salotra P, 2010. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS ONE 5: e10107.
45. Nylen S, Sacks D, 2007. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28: 378-384. (Pubitemid 47385375)
46. Ghalib HW, Piuvezam MR, Skeiky YA, Siddig M, Hashim FA, el-Hassan AM, Russo DM, Reed SG, 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92: 324-329. (Pubitemid 23209013)
47. Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, Rai M, Sundar S, Sacks D, 2011. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis 204: 1134-1137.
48. Zhao E, Xu H, Wang L, Kryczek I, Wu K, Hu Y, Zhou J, Zhang LM, Liu SL, 2012. Bone marrow and the control of immunity. Cell Mol Immunol 9: 11-19.